⌘K

Login Start Free

Home/Filings/4/0001628280-22-005790

4//SEC Filing

Erlander Mark 4

Accession 0001628280-22-005790

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 6:39 PM ET

Size

5.5 KB

Accession

0001628280-22-005790

Insider Transaction Report

Form 4

Period: 2022-03-09

Cardiff Oncology, Inc.CRDF

DirectorChief Executive Officer

Transactions

Award
Stock Options
2022-03-09+370,128→ 1,185,400 total
Exercise: $2.50Exp: 2032-03-09→ Common Stock (370,128 underlying)

Footnotes (1)

[F1]92,532 vest on 3/09/2023. 7,711 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026.

Documents

1 file

4
wf-form4_164695553669989.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001651537

Filing Metadata

Form type: 4
Filed: Mar 9, 7:00 PM ET
Accepted: Mar 10, 6:39 PM ET
Size: 5.5 KB

View on SEC.gov